N.L. Ngcobo, S.O. Akiri, A.O. Ogweno et al.
Polyhedron 203 (2021) 115243
3
in CH2Cl2 (5 mL) and the mixture stirred for 24 h. The solution was
concentrated in vacuo and Et2O (10 mL) added to precipitate an
orange solid. Recrystallization of the crude product by slow diffu-
sion of hexane in solution of dichloromethane containing the com-
pound gave single crystals suitable for X-ray analyses.
Yield = 0.14 g (82%). 1H NMR (400 MHz, CDCl3, d ppm) 1.86 (d,
3H, 3JHH = 7.2 Hz, NCCH3); 2.17 (s, 3H, CCH3); 6.74 (q, 1H, 3JHH = 7.2-
Hz, NCH); 7.32 (d, 1H, 3JHH = 7.2 Hz, 4Ph); 7.38 (t, 2H, 3JHH = 7.6 Hz,
2,6Ph); 7.45 (d, 2H, 3JHH = 7.6 Hz, 3,5Ph); 7.78 (t, 2H, 3JHH = 8.4 Hz,
NCH); 7.42 (t, 1H, JHH = 4.0 Hz 4Ph) 7.48–7.70 (m, 4H, 2,3,5,6Ph);
3
7.78 (dt, 2H; 8.09, 3,5Py) 7.80 (t, 1H, JHH = 7.6 Hz, 4Py); 8.09 (s,
1H, Himine), 9.42 (d, 1H, 3JHH = 5.2 Hz, 6Py). 13C NMR (400 MHz, CDCl3,
d ppm): 24.58 (CH3-C), 69.55 (C-CH3), 121.46 (C-Py), 124.69 (C-Ar),
126.73 (C-Py), 127.02 (2C-Ar), 128.51 (2C-Ar), 136.48 (C-Py),
144.60 (C-Ar), 149.34 (C-Py), 154.82 (C-Py), 160.46 (C@N). MS (ESI
+): calcd. m/z (100%) = 385.96, Found: m/z (M+Na) = 408.86. FT-IR:
t
C
(C@N)pyridine = 1445 cmꢀ1 t(C@N)imine = 1594 cmꢀ1. Anal. Calcd. for
;
14H14N2Cl2Pd: C, 43.50; H, 3.39; N, 7.25. Found: 43.86, 3.64, 7.37.
3
3
4,6Py); 8.15 (t, 1H, JHH = 7.6 Hz, 3Py); 9.50 (d, 1H, JHH = 5.6 Hz,
6Py). 13C NMR (400 MHz, CDCl3, d ppm): 19.39 (CH3-CN), 26.60
(CH3-C), 61.75 (C-Ph), 125.21 (C-Py), 126.22 (C-Ar), 127.61 (C-Py),
128.26 (C-Ar), 128.31 (C-Ar), 128.58 (C-Ar), 129.04 (C-Ar), 133.10
(C-Py), 137.19 (C-Ar), 141.07 (C-Py), 151.49 (C-Py), 158.28 (CN-
CH3). MS (ESI+): calcd. m/z (100%) = 399.97; Found: m/z (M
3.2.7. [{(S)-N-(2-(diphenylphosphino)benzylidene)-1-
phenylethanamine} PdCl2] (5)
To a solution of [Pd(COD)Cl2] (0.05 g, 0.19 mmol) with dichlor-
omethane (5 mL) was added to ligand L5 (0.07 g, 0.19 mmol) in
CH2Cl2 (5 mL) and the mixture stirred for 24 h. The solution was
concentrated in vacuo and diethylether (10 mL) added to precipi-
tate a yellow solid. Recrystallization of the crude product by slow
diffusion of hexane in solution of dichloromethane containing
the compound gave single crystals suitable for X-ray analyses.
Complex 6 Yield = 0.06 g (81%). 1H NMR (400 MHz, CDCl3, d
+Na) = 424.37. FT-IR: t ; t(C@N)imine = 1593-
(C@N)pyridine = 1438 cmꢀ1
cmꢀ1. Anal. Calcd. for C15H16N2Cl2Pd: C 44.97, H 3.77, N 6.99.
Found: C, 44.89; H 3.84; N, 6.84.
3.2.4. [{(R)-1-phenyl-N-(1-(pyridin-2-yl)ethylidene)ethanamine}
PdCl2] (2)
3
3
ppm):1.57 (d, 3H, JHH = 7.0 Hz, CCH3); 6.80 (q, 1H, JHH = 6.6 Hz,
NCH); 6.95 (t, 1H, 3JHH = 7.7 Hz, Haromatic); 7.12 (d, 2H, 3JHH = 6.8 Hz,
Haromatic); 7.31 (m, 4H, Haromatic); 7.37 (d, 5H, Haromatic); 7.60 (s, 1H,
Complex 2 was synthesized following the procedure described
for compound 1 using [Pd(COD)Cl2] (0.10 g, 0.39 mmol) and L2
(0.09 g, 0.39 mmol) were used. Yield = 0.14 g (89%). Recrystalliza-
tion of complex 2 by slow evaporation of CH2Cl2 solution afforded
single crystals suitable for X-ray analyses 1H NMR (400 MHz,
H
aromatic); 7.69 (m, 1H, Haromatic); 7.73 (s, 1H, Himine). 13C NMR
(400 MHz, CDCl3, d ppm): 26.60 (CH3), 69.87 (C-CH3), 116.61 (C-
Ar), 121.55 (C-Ar), 122.04 (C-Ar), 124.01 (C-Ar), 124.62 (C-Ar),
126.10 (C-Ar), 126.67 (C-Ar), 128.31 (C-Ar), 128.91 (C-Ar), 129.02
(C-Ar), 129.14 (C-Ar), 132.19 (C-Ar), 132.61 (C-Ar), 133.10 (C-Ar),
133.85 (C-Ar), 134.38 (2C-Ar), 134.49 (C-Ar), 135.51 (C-Ar),
135.59 (C-Ar), 137.19 (C-Ar), 137.66 (C-Ar), 139.01 (C-Ar), 162.03
(C-Ar), 162.11 (C@N). MS (ESI+): calcd. m/z (100%) = 569.01, Found:
m/z (M+H) = 573.0. 31P NMR (400 MHz, CDCl3, d ppm): 31.4 (s). FT-
3
CDCl3, d ppm): 1.87 (d, 3H, JHH = 7.2 Hz, NCCH3); 2.16 (s, 3H,
3
3
CCH3); 6.73 (q, 1H, JHH = 7.2 Hz, NCH); 7.32 (d, 1H, JHH = 7.2 Hz,
3
3
4Ph); 7.39 (t, 2H, JHH = 7.6 Hz, 2,6Ph); 7.45 (d, 2H, JHH = 7.6 Hz,
3,5Ph); 7.72 (d, 2H, 3JHH = 8.4 Hz, 4,5Py); 8.16 (t, 1H, 3JHH = 7.6 Hz,
3Py); 9.52 (d, 1H, JHH = 5.6 Hz, 6Py). 13C NMR (400 MHz, CDCl3, d
3
ppm): 19.39 (CH3-CN), 26.60 (CH3-C), 61.75 (C-Ph), 125.21 (C-Py),
126.22 (C-Ar), 127.61 (C-Py), 128.26 (C-Ar), 128.31 (C-Ar), 128.58
(C-Ar), 129.04 (C-Ar), 133.10 (C-Py), 137.19 (C-Ar), 141.07 (C-Py),
151.49 (C-Py), 158.28 (CN-CH3). MS (ESI+): calcd. m/z
(100%) = 399.97; Found: m/z = 400.0. FT-IR: t(C@N)pyridine = 1445-
IR:
t
(C@N)imine = 1626 cmꢀ1. Anal. Calcd. for C27H24NCl2PPdꢂCH2Cl2:
C, 55.73; H, 4.19; N, 2.39. Found: C, 55.69; H, 4.07; N, 2.08.
3.2.8. [{(R)-N-(2-(diphenylphosphino)benzylidene)-1-
phenylethanamine} PdCl2] (6)
cmꢀ1; 1601
t
(C@N)imine = 1601 cmꢀ1. Anal. Calcd. for C15H16N2Cl2Pd:
C, 44.67; H, 3.77; N, 6.99. Found: 44.77, 3.73, 7.27.
Complexes 6 was synthesized following the procedure
described for compound 5 using Pd(COD)Cl2] (0.15 g, 0.51 mmol)
3.2.5. [{(S)-1-phenyl-N-((pyridin-2-yl)methylene)ethanamine}PdCl2
(3)
and L6 (0.2 g, 0.51 mmol). Complex 7 Yield = 0.22 g (77%). 1H
3
NMR (400 MHz, CDCl3, d ppm): 1.57 (d, 3H, JHH = 7.0 Hz, CCH3);
Complex 3 was synthesized following the procedure described
for compound 1 using [Pd(COD)Cl2] (0.10 g, 0.39 mmol) and L3
(0.08 g, 0.39 mmol). Yield = 0.12 g (80%). Recrystallization of com-
plex 3 by slow diffusion of hexane in a CH2Cl2 solution afforded
single crystals suitable for X-ray analyses 1H NMR (400 MHz,
6.80 (q, 1H, 3JHH = 6.8 Hz, NCH); 6.95 (t, 1H, 3JHH = 7.8 Hz, Haromatic);
7.18 (d, 2H, 3JHH = 6.8 Hz, Haromatic); 7.31 (m, 5H, Haromatic); 7.47 (d,
5H, Haromatic); 7.54 (m, 4H, Haromatic); 7.60 (m, 1H, He); 7.69 (m, 1H,
H
aromatic). 7.74 (s, 1H, Himine). 13C NMR (400 MHz, CDCl3, d ppm):
26.60 (CH3), 69.87 (C-CH3), 116.61 (C-Ar), 121.55 (C-Ar), 122.04
(C-Ar), 124.01 (C-Ar), 124.62 (C-Ar), 126.10 (C-Ar), 126.67 (C-Ar),
128.31 (C-Ar), 128.91 (C-Ar), 129.02 (C-Ar), 129.14 (C-Ar), 132.19
(C-Ar), 132.61 (C-Ar), 133.10 (C-Ar), 133.85 (C-Ar), 134.38 (2C-
Ar), 134.49 (C-Ar), 135.51 (C-Ar), 135.59 (C-Ar), 137.19 (C-Ar),
137.66 (C-Ar), 139.01 (C-Ar), 162.03 (C-Ar), 162.11 (C@N). 31P
NMR (400 MHz, CDCl3, d ppm): 31.4 (s). MS (ESI+): calcd. m/z
3
3
3
CDCl3, d ppm): 1.89 (d, 3H, JHH = 6.8 Hz, CCH3); 6.09 (q, 1H,
-
-
3
JHH = 7.2 Hz, NCH); 7.44 (t, 1H, JHH = 4.0 Hz, 4Ph); 7.47 (d, 4H,
3
JHH = 4.4 Hz, 2,3,5,6Ph); 7.67 (t, 1H, JHH = 6.8 Hz, 5Py); 7.76 (d,
1H, 3JHH = 7.6 Hz, 3Py); 7.88 (s, 1H, 4Py); 8.11 (t, 1H, 3JHH = 7.6 Hz,
H
imine); 9.35 (d, 1H, 3JHH = 5.2 Hz, 6Py). 13C NMR (400 MHz, CDCl3, d
ppm): 21.0 (CH3-C), 64.74 (C-CH3), 128.56 (3C-Ar, C-Py), 129.32
(2C-Ar), 138.15 (C-Py), 140.45 (C-Ar), 151.14 (C-Py), 155.54 (C-
Py), 167.04 (C@N). MS (ESI+): calcd. m/z (100%) = 385.96, Found:
(100%)
= 569.01, Found: m/z (M+H) = 573.0. FT-IR: t(C@N)
= 1625 cmꢀ. 1 Anal. Calcd. for C27H24NCl2PPdꢂCH2Cl2: C, 54.82;
imine
m/z = 386.42. FT-IR: t(C@N)pyridine = 1445 cmꢀ1
;
t(C@N)imine = 1595-
H, 4.15; N, 2.34. Found: C, 54.96; H, 4.18; N, 2.12.
cmꢀ1. Anal. Calcd. for C14H14N2Cl2Pd: C, 43.50; H, 3.39; N, 7.25.
Found: 43.68, 3.54, 7.77.
3.3. X-ray crystallography analyses of thee complexes
3.2.6. [{(R)-1-phenyl-N-((pyridin-2-yl)methylene)ethanamine}PdCl2]
(4)
The X-ray data were recorded on a Bruker Apex Duo equipped
with an Oxford Instruments Cryojet operating at 100(2) K and an
Incoatec micro-source operating at 30 W power. The data were col-
Complex 2 was synthesized following the procedure described
for compound 1 using [Pd(COD)Cl2] (0.10 g, 0.39 mmol) and L4
(0.08 g, 0.39 mmol). Yield = 0.11 g (75%). Recrystallization of com-
plex 4 was done by slow evaporation of CH2Cl2 solution afforded sin-
gle crystals suitable for X-ray analyses. 1H NMR (400 MHz, CDCl3, d
lected with Mo Ka (k = 0.71073 Å) radiation at a crystal-to-detector
distance of 50 mm. The following conditions were used for the data
collection: omega and phi scans with exposures taken at 30 W X-
ray power and 0.50° frame widths using APEX2 [57]. The data were
reduced with the Programme SAINT [58] using outlier rejection,
3
3
ppm): 1.90 (d, 3H, JHH = 6.8 Hz, CCH3); 6.12 (q, 1H, JHH = 7.2 Hz,
8